Exjade
( DrugBank: - / KEGG DRUG: - )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 254 | Porphyria | 1 |
| 284 | Diamond-Blackfan anemia | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 286 | Hereditary sideroblastic anemia | 4 |
254. Porphyria
Clinical trials : 85 / Drugs : 67 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
284. Diamond-Blackfan anemia
Clinical trials : 41 / Drugs : 123 - (DrugBank : 34) / Drug target genes : 24 - Drug target pathways : 125
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
286. Hereditary sideroblastic anemia
Clinical trials : 7 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 40
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|